Cutera (NASDAQ:CUTR) Coverage Initiated by Analysts at StockNews.com

Research analysts at StockNews.com assumed coverage on shares of Cutera (NASDAQ:CUTR) in a report released on Monday. The firm set a “sell” rating on the medical device company’s stock.

Cutera Stock Up 0.4 %

Shares of CUTR opened at $0.40 on Monday. The business’s 50 day moving average price is $0.39 and its 200-day moving average price is $0.74. The stock has a market cap of $8.14 million, a P/E ratio of -0.06 and a beta of 1.26. Cutera has a 52 week low of $0.28 and a 52 week high of $3.73.

Institutional Trading of Cutera

An institutional investor recently raised its position in Cutera stock. Squarepoint Ops LLC raised its position in shares of Cutera, Inc. (NASDAQ:CUTR) by 164.5% during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 113,964 shares of the medical device company’s stock after purchasing an additional 70,870 shares during the quarter. Squarepoint Ops LLC owned 0.57% of Cutera worth $172,000 as of its most recent SEC filing. Institutional investors and hedge funds own 90.70% of the company’s stock.

About Cutera

Cutera, Inc provides aesthetic and dermatology solutions for medical practitioners worldwide. It develops, manufactures, and markets energy-based product platforms for medical practitioners; and distributes third-party manufactured skincare products. The company provides AviClear for the treatment of mild, moderate, and severe inflammatory acne vulgaris; Secret PRO, a device that utilizes fractional CO2 for skin resurfacing and radio frequency (RF) microneedling for skin revitalization; truFlex, a bio-electrical muscle stimulation device designs to strengthen, firm and tone the abdomen, buttocks, and thighs; and excel V/V+, a vascular and benign pigmented lesion treatment platform.